EDGAR Filing Documents for 0001279569-16-004156

Form 8-K - Current report:

SEC Accession No. 0001279569-16-004156

Filing Date

2016-08-10

Accepted

2016-08-10 16:32:51

Documents

Period of Report

2016-08-10

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v446069_8k.htm	8-K	20753
2	EXHIBIT 99.1	v446069_ex99-1.htm	EX-99.1	76089
3	GRAPHIC	logo.jpg	GRAPHIC	1839
	Complete submission text file	0001279569-16-004156.txt		100576

Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9

Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449

Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

IRS No.: 981226819 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37426 | Film No.: 161821887
SIC: 2834 Pharmaceutical Preparations